Status:
COMPLETED
Flow Controlled Ventilation (FCV) With the Evone Ventilator and Tritube Versus Volume Controlled Ventilation (VCV)
Lead Sponsor:
University Hospital, Antwerp
Conditions:
Pulmonary Ventilation
Eligibility:
All Genders
18-75 years
Phase:
PHASE3
Brief Summary
The Evone® ventilator is a new device capable of lung ventilation through a narrow-bore cannula, the Tritube.Two ventilation modes are possible: high frequency jet ventilation (HFJV) and flow-controll...
Detailed Description
The Evone® (Ventinova Medical, Eindhoven, The Netherlands) is an automated mechanical ventilator providing pulmonary ventilation by generating a continuous flow into the patient's lungs during inspira...
Eligibility Criteria
Inclusion
- Scheduled for craniotomy in the supine position due to intracranial neoplasia
- American Society of Anesthesiologists (ASA) Class ≤ 3
- BMI \< 30
Exclusion
- Respiratory disease
- Severe cardiovascular disease
- Non-sinus rhythm
- Poorly controlled hypertension
- Patients with known allergies for rocuronium, propofol or remifentanil
- Emergency procedures
Key Trial Info
Start Date :
March 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 5 2019
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT03873233
Start Date
March 15 2019
End Date
August 5 2019
Last Update
September 6 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University hospital Antwerp
Edegem, Antwerp, Belgium, 2650